Form 4: Regeneron EVP Marion McCourt Reports Stock Disposal for Tax Obligations
SEC Form 4
Marion McCourt, EVP Commercial at Regeneron Pharmaceuticals, disposed of 759 shares of common stock on December 16, 2024, to cover tax obligations.
Summary
- On December 16, 2024, Marion McCourt, the EVP Commercial at Regeneron Pharmaceuticals, disposed of 759 shares of common stock.
- The transaction was executed at a price of $730.81 per share.
- This disposal was related to covering tax obligations.
- Following the transaction, McCourt directly owns 14,230 shares of Regeneron common stock.
- McCourt also indirectly owns 174 shares through a 401(k) plan.
Sentiment
Score: 5
Explanation: Neutral sentiment as the filing simply reports a stock disposal for tax purposes, a routine transaction.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies. They can be influenced by factors such as tax planning, diversification, and company performance. These transactions are closely monitored by investors as they can provide insights into an executive's perspective on the company's future prospects.
Stakeholder Impact
- The transaction is unlikely to have a significant impact on shareholders, as it is a routine disposal of shares by an executive for tax purposes.
Key Dates
| Date | Description |
|---|---|
| 12/16/2024 | Date of stock disposal transaction |
| 12/18/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.